Yale University

Publications

Filters: Keyword is Drug Interactions  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
V
Vivian, James, Hassan Saleheen, Merrill Singer, Juhem Navarro, and Greg Mirhej. "Under the counter: the diffusion of narcotic analgesics to the inner city street." Journal of ethnicity in substance abuse 4, no. 2 (2005): 97-114. Abstract
Vergara-Rodriguez, Pamela, Mary Jo Tozzi, Michael Botsko, Vijay Nandi, Frederick Altice, James E. Egan, Patrick G. O'Connor, Lynn E. Sullivan, and David A. Fiellin. "Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
T
Tetrault, Jeanette M., Janet P. Tate, Kathleen A. McGinnis, Joseph L. Goulet, Lynn E. Sullivan, Kendall Bryant, Amy C. Justice, and David A. Fiellin. "Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone." Alcoholism, clinical and experimental research 36, no. 2 (2012): 318-24. Abstract
S
Sullivan, Lynn E., Jeanette Tetrault, Deepa Bangalore, and David A. Fiellin. "Training HIV physicians to prescribe buprenorphine for opioid dependence." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 13-8. Abstract
Singer, Merrill. "New drugs on the street: an introduction." Journal of ethnicity in substance abuse 4, no. 2 (2005): 1-7.
Singer, Merrill, Greg Mirhej, Susan Shaw, Hassan Saleheen, James Vivian, Erica Hastings, Lucy Rohena, DeShawn Jennings, Juhem Navarro, Claudia Santelices et al. "When the drug of choice is a drug of confusion: embalming fluid use in inner city Hartford, CT." Journal of ethnicity in substance abuse 4, no. 2 (2005): 73-96. Abstract
Schensul, Jean J., Sarah Diamond, William Disch, Rey Bermudez, and Julie Eiserman. "The diffusion of ecstasy through urban youth networks." Journal of ethnicity in substance abuse 4, no. 2 (2005): 39-71. Abstract
Saber-Tehrani, Ali S., Robert Douglas Bruce, and Frederick L. Altice. "Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence." The American journal of drug and alcohol abuse 37, no. 1 (2011): 1-11. Abstract
R
Rahmanian, Shiva, Mary Ellen Wewers, Susan Koletar, Nancy Reynolds, Amy Ferketich, and Philip Diaz. "Cigarette smoking in the HIV-infected population." Proceedings of the American Thoracic Society 8, no. 3 (2011): 313-9. Abstract
M
Mugavero, Michael J., Margaret May, Ross Harris, Michael S. Saag, Dominique Costagliola, Matthias Egger, Andrew Phillips, Huldrych F. Günthard, Francois Dabis, Robert Hogg et al. "Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?" AIDS (London, England) 22, no. 18 (2008): 2481-92. Abstract
McCance-Katz, Elinore F., David E. Moody, Gene D. Morse, Qing Ma, Robin DiFrancesco, Gerald Friedland, Patricia Pade, and Petrie M. Rainey. "Interaction between buprenorphine and atazanavir or atazanavir/ritonavir." Drug and alcohol dependence 91, no. 2-3 (2007): 269-78. Abstract
McCance-Katz, Elinore F., David E. Moody, Patrick F. Smith, Gene D. Morse, Gerald Friedland, Patricia Pade, Jennifer Baker, Anika Alvanzo, Peter Jatlow, and Petrie M. Rainey. "Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S235-46. Abstract
McCance-Katz, Elinore F., Lynn E. Sullivan, and Srikanth Nallani. "Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 1 (2010): 4-16. Abstract
McCance-Katz, Elinore F., Petrie M. Rainey, Patrick Smith, Gene Morse, Gerald Friedland, Marc Gourevitch, and Peter Jatlow. "Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 2 (2004): 163-80. Abstract
McCance-Katz, Elinore F., David E. Moody, Gene D. Morse, Gerald Friedland, Patricia Pade, Jennifer Baker, Anika Alvanzo, Patrick Smith, Abayomi Ogundele, Peter Jatlow et al. "Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S224-34. Abstract
McCance-Katz, Elinore F., David E. Moody, Sudha Prathikanti, Gerald Friedland, and Petrie M. Rainey. "Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients." Drug and alcohol dependence 118, no. 2-3 (2011): 326-34. Abstract
K
Kalichman, Seth C., Christina M. Amaral, Denise White, Connie Swetsze, Howard Pope, Moira O. Kalichman, Chauncey Cherry, and Lisa Eaton. "Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS." AIDS patient care and STDs 23, no. 6 (2009): 449-54. Abstract
F
Friedland, Gerald, Salim Abdool Karim, Quarraisha Abdool Karim, Umesh Lalloo, Christopher Jack, Neel Gandhi, and Wafaa El Sadr. "Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S421-8. Abstract
Friedland, Gerald, Laurie Andrews, Tanya Schreibman, Sangeeta Agarwala, Leith Daley, Michael Child, Julia Shi, Yonghua Wang, and Edward O'Mara. "Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract
Fiellin, David A., Gerald H. Friedland, and Marc N. Gourevitch. "Opioid dependence: rationale for and efficacy of existing and new treatments." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S173-7. Abstract
E
Eiserman, Julie M., Sarah Diamond, and Jean J. Schensul. ""Rollin' on E": a qualitative analysis of ecstasy use among inner city adolescents and young adults." Journal of ethnicity in substance abuse 4, no. 2 (2005): 9-38. Abstract
B
Bruce, Douglas R., Thomas F. Kresina, and Elinore F. McCance-Katz. "Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users." AIDS (London, England) 24, no. 3 (2010): 331-40. Abstract
Bruce, Douglas R., David E. Moody, Frederick L. Altice, Marc N. Gourevitch, and Gerald H. Friedland. "A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice." Expert review of clinical pharmacology 6, no. 3 (2013): 249-69. Abstract
Bruce, Douglas R., Frederick L. Altice, Marc N. Gourevitch, and Gerald H. Friedland. "Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice." Journal of acquired immune deficiency syndromes (1999) 41, no. 5 (2006): 563-72. Abstract
Bruce, Robert Douglas, Frederick L. Altice, David E. Moody, Gene D. Morse, Laurie Andrews, Shen-Nan Lin, Wenfang B. Fang, Qing Ma, and Gerald H. Friedland. "Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir." Journal of acquired immune deficiency syndromes (1999) 54, no. 5 (2010): 511-4. Abstract
Bruce, Douglas R., P. Winkle, Jm Custodio, X. Wei, M. S. Rhee, Bp Kearney, S. Ramanathan, and Gerald H. Friedland. "Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy 57, no. 12 (2013): 6154-7. Abstract
Bruce, Douglas R., David E. Moody, Wenfang B. Fang, Diane Chodkowski, Laurie Andrews, and Gerald H. Friedland. "Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone." The American journal of drug and alcohol abuse 37, no. 4 (2011): 224-8. Abstract
Bruce, Douglas R., Frederick L. Altice, David E. Moody, Shen-Nan Lin, Wenfang B. Fang, John P. Sabo, Jan M. Wruck, Peter J. Piliero, Carolyn Conner, Laurie Andrews et al. "Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone." Drug and alcohol dependence 105, no. 3 (2009): 234-9. Abstract
Bruce, Douglas R., and Frederick L. Altice. "Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
Bruce, Douglas R., and Frederick L. Altice. "Clinical care of the HIV-infected drug user." Infectious disease clinics of North America 21, no. 1 (2007): 149-79, ix. Abstract
A
Altice, Frederick L., Adeeba Kamarulzaman, Vincent V. Soriano, Mauro Schechter, and Gerald H. Friedland. "Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs." Lancet 376, no. 9738 (2010): 367-87. Abstract